SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data for deramiocel, including a reported slowing of upper-limb decline after placebo patients switched to treatment, is driving attention around its World Muscle Society presentation. Many traders view the results as supportive of the Duchenne muscular dystrophy therapy and the pending FDA review, while others question whether open-label findings resolve the agencys statistical-analysis concerns; short-squeeze talk is also prominent.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A DEA administrative judges pause of the remaining cannabis rescheduling case, pending review of a government report on drug-scheduling procedures, has delayed a recommendation on broader Schedule III treatment. Traders debate whether the procedural delay threatens the catalyst and warrants further selling or is a temporary setback and buying opportunity; the earlier medical-marijuana rule was not reversed.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths SPAC merger and Nasdaq listing, tied to a large planned XRP treasury, are driving attention alongside sharp moves and trading halts. Traders see XRPN and its warrants as leveraged XRP exposure, while others question their valuation and flag merger, redemption, and dilution risks.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vandas positive Phase 3 Hetlioz results in delayed sleep-wake phase disorder are driving attention; the company plans to discuss the data with the FDA and seek an expanded indication. Traders welcomed the trial success and potential new commercial opportunity, while some cautioned that approval is still pending and debated whether the news would translate into sustained share-price gains.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebecs payroll and payments partnerships, particularly its Stellar-based enterprise payroll rollout and MoneyGram connectivity, are fueling discussion about real-world adoption and potential ZBCN utility. Bulls see growing usage as a long-term catalyst, while skeptics argue that partnerships have yet to translate into sustained token demand or price gains; Robinhood and BlackRock links remain speculation.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised 2026 revenue outlook, reflecting stronger demand for Amtagvi and Proleukin, is driving the sharp rally, with analyst upgrades adding to the positive reaction. Traders are debating whether the move could be amplified by short covering, while many also point to upcoming lung-cancer data; others caution about profit-taking and possible dilution.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile shares are drawing attention after Barclays cut its price target ahead of Q3 earnings, warning that earnings upside may be limited while emerging competitionespecially Starlinkcould pressure the outlook. Traders are debating the selloff and fresh lows, with bearish concern about further declines countered by investors who view the weakness as a buying opportunity.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas choice of Amazon Leo over Starlink and reported criticism of Elon Musk are driving discussion, with some traders questioning the decision as United expands Starlink WiFi and citing poor connectivity on Delta flights. A few also speculate about CEO accountability, but the communitys reaction is mixed and the reported remarks are not independently verified here.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings selection to develop the U.S. Navys next-generation F/A-XX fighter is drawing attention, with traders highlighting the multibillion-dollar award as a boost to its defense business and shares rising after the announcement. Some remain cautious, noting that the programs long-term value depends on execution and that commercial production, certification, and labor issues remain concerns.

Six Flags Entertainment Corp. engages in operating amusement parks in North America. It operates amusement parks, water parks, and resorts. The company is headquartered in Charlotte, NC.

Six Flags Entertainment Corp.

Six Flags Entertainment Corp

JANA Partners call for Six Flags to explore a sale is driving discussion, with traders debating whether a transaction could unlock value or distract management from operational execution and debt reduction. The debate is unfolding alongside continued share-price weakness and concerns about the companys heavy debt load.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


John1F

Jon Hifton